Related Experiment Video
Updated: Apr 18, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
The c.301_302delAG PROP1 gene mutation in Romanian patients with multiple pituitary hormone deficiency
Objective:
To establish the frequency of the c.301_302 delAG mutation of the PROP1 gene in Romanian patients with multiple pituitary hormone deficiency (MPHD).
Subjects And Methods:
Somatic assessment, hormonal test, bone age, magnetic resonance imaging of the pituitary gland, and molecular diagnosis were performed in 26 patients with MPHD (7 patients with familial form of MPHD and 19 patients with sporadic form of MPHD).
Results:
The c.301_302delAG mutation was detected in the homozygous state in 10 patients belonging to 5 unrelated families (7 patients with familial history of MPHD and 3 patients with sporadic form of MPHD). Those 10 patients presented variable pituitary hormone deficiency and pituitary morphology.
Conclusions:
The c.301_302delAG homozygous genotype had a high frequency of 38% (10/26), reaching 100% (7/7) in group with familial cases of MPHD and 16% (3/19) in group with sporadic forms of MPHD.
Insights
The PROP1 gene
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Prophet of Pituitary Transcription Factor 1 (PROP1) gene mutations are a significant cause of multiple pituitary hormone deficiency (MPHD).
- Understanding the genetic landscape of MPHD is crucial for diagnosis and genetic counseling.
Purpose of the Study:
- To determine the prevalence of the c.301_302delAG mutation in the PROP1 gene among Romanian patients diagnosed with MPHD.
- To investigate the mutation's frequency in familial versus sporadic forms of MPHD.
Main Methods:
- Conducted comprehensive assessments including somatic evaluation, hormonal testing, bone age determination, pituitary MRI, and molecular genetic analysis.
- Studied a cohort of 26 Romanian patients with MPHD, divided into familial (7 patients) and sporadic (19 patients) groups.
Main Results:
- The c.301_302delAG PROP1 mutation was identified in the homozygous state in 10 out of 26 patients (38.5%).
- This mutation was found in all 7 patients with a familial history of MPHD and in 3 patients with sporadic MPHD.
- Affected individuals exhibited diverse patterns of pituitary hormone deficiencies and pituitary gland morphology.
Conclusions:
- The homozygous c.301_302delAG genotype of the PROP1 gene is a frequent cause of MPHD in the Romanian population, with a 38.5% prevalence.
- The mutation's frequency was notably high in familial cases (100%) and significant in sporadic cases (16%).
- This finding highlights the importance of screening for this specific PROP1 mutation in Romanian MPHD patients.
More Related Videos
Related Concept Videos
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Huntington Disease l: Introduction
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Cushing Syndrome II: Pathophysiology
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...

